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ABSTRACT
Many genes have several, sometimes divergent func-
tions during development. Therefore, timing of gene
knockdown for functional analysis during develop-
ment has to be done with precise temporal control,
as loss of a gene’s function at early stages prevents
its analysis later in development. RNAi, in combin-
ation with the accessibility of chicken embryos, is
an effective approach for temporally controlled
analysis of gene function during neural develop-
ment. Here, we describe novel plasmid vectors that
contain cell type-specific promoters/enhancers to
drive the expression of a fluorescent marker, fol-
lowed directly by a miR30-RNAi transcript for gene
silencing. These vectors allow for direct tracing of
cells experiencing gene silencing by the bright fluor-
escence. The level of knockdown is sufficient to re-
produce the expected pathfinding defects upon
perturbation of genes with known axon guidance
functions. Mixing different vectors prior to electro-
poration enables the simultaneous knockdown of
multiple genes in independent regions of the spinal
cord. This permits complex cellular and molecular
interactions to be examined during development,
in a fast and precise manner. The advancements
of the in ovo RNAi technique that we describe will
not only markedly enhance functional gene analysis
in the chicken, but also could be adapted to other
organisms in developmental studies.
INTRODUCTION
The function of a gene can only be understood in the
context of the entire organism, as it is cell type speciﬁc and
context dependent. The analysis of gene function is par-
ticularly demanding during development, as temporal con-
trol of gene expression adds additional complexity to the
experimental approach. While functional gene analysis in
vertebrates is most commonly performed by gain-of-
function and loss-of-function experiments in the mouse,
many genes involved in the development of the nervous
system cannot be studied. Since many genes play addition-
al roles in early developmental processes, classical gene
knockouts may cause early embryonic lethality that pre-
cludes their analysis in later stages of development. In
such circumstances, perturbation of gene function in a
spatially and temporally deﬁned manner is required. To
some extent, this can be achieved by sophisticated gene
knockout techniques (1). However, the high cost and the
large amount of time required for the production of
multiple transgenic mice is rate limiting in the quest to
gain insight into the functional role of a gene of interest.
Because of its easy accessibility in the egg, the chicken
embryo has been the model of choice for developmental
in vivo studies. In recent years, our lab and others have
used RNA interference (RNAi) and electroporation as a
powerful method to perturb gene expression during devel-
opment. In the chicken, spatiotemporal control of gene
knockdown can be achieved by electroporation of long
double-stranded RNA (dsRNA) (2–7), DNA plasmids en-
coding short hairpin RNAs (shRNAs) (8) or artiﬁcial
microRNAs (miRNAs) (9). These approaches harness the
naturally occurring miRNA biogenesis pathway, a post-
transcriptional gene regulatory mechanism that activates
the RNA-induced silencing complex to evoke gene silenc-
ing in response to dsRNA [reviewed in (10)]. We have pre-
viously used long dsRNA to identify new roles for multiple
genes during neural development (2–7). Alternatively, Das
and colleagues (9) described a plasmid in which a ubiqui-
tously active chicken U6 promoter was used to drive the
expression of an RNA transcript that mimicked the stem–
loop and ﬂanking structure of microRNA30, to ensure its
successful processing by Drosha and Dicer. Following
electroporation, the authors reported the silencing of vari-
ous target genes in the chicken neural tube. However, the
lack of cell type speciﬁcity of these current methods can be
problematic since (i) targeting of distinct subpopulations
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of cells located in the same area is not possible using
manual targeting techniques; (ii) it is difﬁcult to down-
regulate different genes in independent subpopulations
of cells; and (iii) identiﬁcation of cells experiencing gene
knockdown is often indirect (for example, by the co-
electroporation of a ﬂuorescent reporter). Here, we de-
scribe an improvement on current techniques to markedly
enhance the precision and combinatorial possibilities of
in ovo RNAi.
Several recent studies have reported successful gene
knockdown by RNAi in a cell type-speciﬁc manner, either
in vitro [for example (11–13)] or in adult mice using viral
vectors or by crossing transgenic lines [for example,
(11,14,15)]. In these studies, a cell type-speciﬁc RNA poly-
merase II promoter/enhancer is used to drive the tran-
scription of shRNA. However, many of the approaches
described to date do not allow the transfected cells to be
directly identiﬁed within the target tissues. While this
feature may not be necessary for in vitro studies or in thera-
peutic settings (in which the speciﬁc cells experiencing gene
knockdown may not need to be identiﬁed in the context of
the whole tissue or organ), it is crucial for developmental
studies. Electroporation of the neural tube results in a
transfection efﬁciency of 60% of the cells in the electro-
porated area (2). Therefore, accurate analysis of novel
gene function in vivo is only possible when the genetically
perturbed cells are identiﬁable in their environment.
Recent in vitro studies have reported that it is possible
for miRNA targeting speciﬁc genes to be expressed simul-
taneously with protein-coding genes (16–18). Thus, we
decided to directly couple an artiﬁcial miRNA to a ﬂuor-
escent indicator that would enable the faithful identiﬁca-
tion of the transfected cells in vivo. We made plasmids
driven by RNA polymerase II promoters/enhancers that
are speciﬁcally active in different subpopulations of cells
in the neural tube. These enhancers drive the expression of
a single transcript encoding both a ﬂuorescent protein and
up to two different artiﬁcial miRNAs. The placement of
hairpin RNAs within the context of an artiﬁcial miRNA
has been shown to reduce shRNA-mediated toxicity
in vivo (19,20). Electroporation of these constructs in the
developing neural tube of chicken embryos allows for ef-
fective knockdown of target genes in different cell types
that can be traced directly by the expression of ﬂuorescent
markers. In principle, any promoter/enhancer could be
used, potentially making the technique widely applicable
for in vivo studies of gene function during development.
MATERIALS AND METHODS
Plasmids
pRFPRNAiC. pRFPRNAiC (9) was obtained from ARK
Genomics and used for many of the initial assessments of
miRNA activity in the chicken spinal cord. Artiﬁcial
miRNAs targeting ﬁreﬂy Luciferase and Shh were previ-
ously published (9,21). For each of our other genes of
interest, we used the online GenScript siRNA Target
Finder to generate at least three new miRNA target se-
quences (21–22 bp). Novel miRNAs were ampliﬁed by
PCR using Pfu DNA polymerase and cloned into the
ﬁrst or second hairpin insertion sites in pRFPRNAiC, fol-
lowing the protocol provided with the vector. The target
sites for the miRNAs used in subsequent experiments are
shown in Table 1.
Backbone ﬂuorescent constructs. Vector components were
synthesized in a stepwise manner and inserted into a
pBluescript SK+ backbone (pBSK+; Stratagene). An
SV40 polyA sequence ﬂanked by KpnI and XhoI sites
was ampliﬁed from pIRES (Clontech) using the following
primers: 50-AACTCGAGGACATGATAAGATACATT
GATG and 50-AAGGTACCTCGGATTTTACCACATT
TGTAG. The PCR product was digested and inserted into
pBSK+, creating pA/pBSK+. EGFP was ampliﬁed from
pIRES using primers that incorporated SpeI and EcoRI
ﬂanking sites and a b-globin basal promoter (22) upstream
of a Kozak start site. The primers used were: 50- AAACT
AGTGGGCTGGGCATAAAAGTCAGGGCAGAGCC
ATCTATTGCTTACATTGCTTCTACCATGGTGAGC
AAGGGCGAG and 50-AAGAATTCTTACTTGTACA
GCTCGTCCATGCC. The PCR product was cloned up-
stream of polyA in pA/pBSK+, creating EGFP-pA/pBSK+.
Enhanced blue ﬂuorescent protein 2 (EBFP2) (23) was
excised from pBad-EBFP2 (Addgene plasmid 14891) using
XhoI (blunted) and EcoRI, and cloned into the SmaI and
EcoRI sites of pA/BSK+, creating EBFP2-pA/pBSK+.
Humanized Renilla GFP (hrGFPII; Stratagene) was cloned
into pA/pBSK+ on a BamHI/EcoRV fragment, creating
hrGFPII-pA/pBSK+. To enable visualization of axon pro-
jections, we used a membrane-targeted (farnesylated) EGFP
Table 1. Target sequences and vector insertion sites for miRNAs used in this study
Name Gene Target sequence Vector insertion site
miShh (9) Sonic hedgehog ACAAGAAACTCCGAGAGATTTA Second
miLuc (9) Fireﬂy luciferase TGCTGCTGGTGCCAACCCTATT First
mi2Luc (21) Fireﬂy luciferase CGTGGATTACGTCGCCAGTCAA First or Second
mi1AX1 Axonin1 AAGTACCACGTCTCAGTGAGA First
mi2AX1 Axonin1 AAGTGACGCTGACGTGTCGAG First
mi3AX1 Axonin1 AAGGCACTTATGAGTGCGAGG First
mi4AX1 Axonin1 AAGGAGGCCACCAGGCAACATC First
mi5AX1 Axonin1 AAGCAGATGCGCACCAATCCTG First
mi6AX1 Axonin1 AACCTCTACATTGCCAAGACAG First
miGPC1 Glypican1 AAGCCTGTATGGAGAATTGTAC First
miWnt7a Wnt7a AAGCAGTTCAAGTCGAACCAGT Second
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(EGFPf; Clontech). Where relevant, the miRNA cassette
containing ﬂanking regions and two miRNA insertion
sites was excised from pRFPRNAiC using KpnI
(blunted) and HindIII, and inserted into the EcoRV and
HindIII sites of the ﬂuorescent backbone vectors. These
were then used in combination with cell type-speciﬁc en-
hancers/promoters (see below) to drive expression of
ﬂuorescent protein, with or without miRNA, in the
chicken spinal cord.
Promoters/enhancers. A 1.6 kb chicken actin promoter
was excised from pMES (provided by C. Krull) using
BamHI and SpeI. bactin-mRFP1 was excised from
pRFPRNAiC using SalI and EcoRI. Constructs were
electroporated at 0.2–0.5 mg/ml.
We obtained the Hoxa1enIII-TATA-Cre-IRESAP-pA
construct from A. Klar. The 0.85 kb Hoxa-1 enhancer
element III (containing retinoic acid response elements)
and TATA box were excised using NotI and SpeI.
Constructs were bilaterally electroporated at 0.5–1.0 mg/ml.
The 1.5 kb Math1 enhancer (24) (mouse Atonal
homolog; Genbank accession AF218258) was provided
in pMath1-Gal4/AD by S. Arber, and was subsequently
cloned upstream of the b-globin basal promoter, the
EGFPf-coding region and SV40 polyadenylation se-
quences (in EGFPf-pA/pBSK+). Constructs were
electroporated unilaterally at 0.7 mg/ml.
In ovo electroporation
Fertilized eggs obtained from a local supplier were incu-
bated at 38.5C for 3 days prior to windowing. Embryos
were staged according to Hamburger and Hamilton (25).
Extra-embryonic membranes were carefully removed at
HH17-18.5, and the central canal of the spinal cord was
injected with a mix of plasmid DNA and Trypan blue to
enable visualization of the injection solution. Unilateral
transfection was achieved by electroporation (ﬁve pulses
of 25V, 50ms duration) as described previously (2) using a
BTX ECM830 square wave electroporator (Harvard
Instruments). Bilateral electroporation was performed
using ﬁve pulses of 18 V, 50ms duration and then
switching the polarity of the electrodes, repositioning
and repeating the electroporation. Efﬁciency and
accuracy of electroporation was assessed by the expression
of the relevant ﬂuorescent protein/s.
Immunohistochemistry
Staining of 25-mm-thick cryostat sections was carried out
as described previously (26). Primary antibodies used in
this study were as follows: mouse anti-Shh (5E1), mouse
anti-myc (9E10), mouse anti-Nkx2.2 (74.5A5), mouse
anti-Pax7, mouse anti-Islet1 (40.2D6), mouse anti-
HNF3b (4C7), rabbit anti-Axonin1, goat anti-NgCAM,
rabbit anti-cleaved caspase-3 (Asp175; Cell Signaling
Technology) and goat anti-GFP-FITC (Rockland).
All monoclonal antibodies were obtained from
Developmental Studies Hybridoma Bank. Fluorophore-
conjugated secondary antibodies were purchased
from Jackson ImmunoResearch Laboratories (donkey
anti-mouse IgG-Cy3, goat anti-mouse IgG-Cy3, donkey
anti-rabbit IgG-Cy3 and goat anti-rabbit IgG-Alexa488)
or Invitrogen (donkey anti-mouse IgG-Alexa488, donkey
anti-goat IgG-Alexa488 and goat anti-mouse IgG-
Alexa488).
Fluorescence intensity recordings
Electroporated embryos were processed in parallel and
immunolabelled for Shh as described. Digital images of
red and green ﬂuorescent channels were captured using
the same camera settings for all sections within the same
experiment. Only those sections where the ﬂoor-plate
region was successfully targeted (as evident by the expres-
sion of RFP or EGFP as appropriate) were used. We
analyzed 7–12 sections per condition, taken from at least
four different embryos. Fluorescent intensity was
calculated using the Gray Value (Mean) function within
Adobe Photoshop CS3 software. The area to be sampled
was deﬁned by drawing a triangle, starting at the midline
just dorsal to the ﬂoor plate and extending out to the
motor nerve exit points and along the ventral border of
the spinal cord. A background recording for each image
was taken from the region adjacent to the dorsal root
entry zone, where Shh is not expressed. The background
recording was subtracted, to give a ﬁnal ﬂuorescence in-
tensity value for each section. The data were subjected to
statistical analysis (see below).
Efﬁciency of bilateral in ovo electroporation
The efﬁciency of bilateral electroporation was assessed on
the basis of expression of hrGFPII. Embryos were bilat-
erally electroporated with bactin-hrGFPII (0.25 mg/ml) at
HH17-18 and sacriﬁced at HH26. The electroporated area
of the spinal cord was removed and dissociated into a
single-cell suspension, and the percentage of green cells
was determined in a Neubauer chamber. The percentage
of hrGFPII-expressing cells was calculated from an
average of four embryos±SEM.
Quantiﬁcation of axon guidance phenotypes
Embryos were sacriﬁced at HH25-26 and the trajectory of
commissural axons was analyzed in an open-book conﬁg-
uration (Figure 4F). In the embryos electroporated with
Math1-EGFPf constructs, the pathﬁnding behavior of
commissural axons was directly visualized by the expres-
sion of membrane-bound EGFP. The scoring of pheno-
types was performed by analysis of the caudal part of each
open book. The open books were classiﬁed as abnormal if
a bundle of more than ﬁve green axons was present along
the ipsilateral ﬂoor-plate border. At least six embryos were
examined in each condition. Alternatively, Fast-DiI (5mg/
ml; Molecular Probes) was applied by focal injection of
DiI into dorsal commissural neurons, as previously
described (27). Labeled axons at the midline were docu-
mented by confocal microscopy (Leica SP2, or Olympus
DSU coupled to BX61 microscope). Only DiI injections
sites that were in the appropriate location in the
dorsal-most part of the spinal cord, and within the
region expressing ﬂuorescent protein, were included in
the analysis. As it was impossible to count axons at indi-
vidual injection sites, the percentage of axons displaying
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abnormalities was estimated, and the injection site was
classiﬁed as showing an ‘ipsilateral’ phenotype if >10%
of the labeled axons made ipsilateral errors, a ‘ﬂoor-plate
stalling’ phenotype if >50% of axons stalled within the
ﬂoor plate, or a ‘no turning’ phenotype if >50% of axons
failed to make a turning decision on the contralateral side
of the ﬂoor plate. In a single abnormal DiI injection site, it
was possible that more than one class of phenotypic error
was observed (for example, both ‘ipsilateral’ errors and
‘ﬂoor-plate stalling’ errors). The total number of DiI
sites in each condition was pooled and an overall percent-
age of each phenotype was calculated and subjected to
statistical analysis (see below).
In situ hybridization
The speciﬁc downregulation of the target genes was
veriﬁed by performing in situ hybridization using probes
produced from chicken cDNAs that were previously
generated in the lab, or ESTs obtained from
Geneservice. The sequences used corresponded to a
1.5-kb fragment from the 50-UTR and ORF of Axonin1
(Genbank accession NM_001004395), a 1.4-kb fragment
of the 30-UTR of Glypican1 (similar to ChEST 986o8;
Genbank accession CR389412.1), 0.7-kb fragment of
Glypican4 (ChEST 335n21), a 0.9-kb fragment of Wnt4
(ChEST 179l4) and a 0.7-kb fragment from the ORF
and 30-UTR of Wnt7a (ChEST 543m22; bp 491–1228 of
Genbank accession NM_204292). In situ hybridization
was carried out essentially as described (28), using
digoxigenin-labeled in situ probes.
In vitro screening of candidate miRNAs
We used a multiple transfection protocol, modiﬁed from
that of Yamamoto and colleagues (29), to maximize the
number of cultured cells expressing each miRNA, and
then assessed the ability of each miRNA to suppress the
expression of its target gene. This approach approximated
the production of a ‘stable cell line’ expressing each
miRNA, allowing different miRNAs to be rapidly tested
side by side. Since the cell machinery required for miRNA
biogenesis is highly conserved in eukaryotes (10), we
reasoned that COS-7 cells should provide a relevant
readout of our chicken sequences. Conﬂuent COS-7 cells
were diluted 1:10 in DMEM (Gibco) with 10% fetal calf
serum and plated into eight-well Labtek dishes (300ml/
well). Cells were grown at 37C with 5% CO2 for 60 h
before the ﬁrst transfection. Lipofectamine reagent
(0.6 ml/well in 25 ml of OptiMEM) was mixed with each
pRFPRNAi vector (125 ng/well in 25 ml of OptiMEM),
incubated for 30–45min, and then added to the cells in
200ml of DMEM+10% FCS. Transfected cells were
incubated for 6 h, and then transfected again. The follow-
ing morning, the transfection process was repeated a third
time, but this time we also co-transfected a ‘reporter’
pAX1-myc/his construct (50 ng/well), in which a CMV
promoter drives the expression of myc/his-tagged
chicken Axonin1. Cells were incubated for another 24 h
before ﬁxation in 4% PFA and immunolabeling for
myc. Brieﬂy, ﬁxed cells were washed in PBS, treated for
20min with 0.1% Triton-X in PBS, blocked in 2% BSA
and incubated for 2 h with 9E10 antibody against myc.
Cells were washed in PBS, and then incubated for 1 h
with goat anti-mouse IgG, conjugated to Alexa488,
before washing and mounting in Mowiol reagent.
We used the expression of RFP in each well to assess the
relative transfection rates of the miRNA-expressing
vectors and found that 70% of the cells in each well
were transfected. We observed no differences in the trans-
fection rates between different wells within the same ex-
periment. The level of myc staining was used as an
indicator of the efﬁciency of each miRNA to knockdown
Axonin1, using the ‘empty vector’ condition (pRFPRNAi
without a miRNA) as a reference. In addition to the six
speciﬁc miRNAs targeted against Axonin1, we used a
miRNA against Glypican1 (an unrelated gene) as a
negative control. Myc staining in each well was visually
scored as ‘no knockdown’, ‘weak knockdown’ or ‘strong
knockdown’. miRNAs eliciting ‘weak’ or ‘strong’ knock-
down were tested further in vivo. All experiments were
batch processed in parallel to minimize variability between
wells and repeated three times to conﬁrm the results.
Statistical analysis
For the Shh immunoﬂuorescence intensity recordings,
we analyzed 7–12 sections, from at least four embryos
per condition. The average ﬂuorescence intensity of Shh
was calculated for each condition and the data were sub-
jected to ANOVA analysis and the Tukey’s HSD test.
Average percentage values provided in the text were nor-
malized to the untreated control condition (100%), and
are expressed ±SEM.
For analysis of axon guidance phenotypes observed in
DiI injection sites, raw data were subjected to a one-tailed
Fisher’s exact test and chi-square test of association. At
least 6 embryos and 50 DiI injection sites were analyzed
for each condition.
We used the VassarStats Website for Statistical
Computation (Vassar College; Richard Lowry
1998–2011; http://faculty.vassar.edu/lowry/VassarStats.
html).
RESULTS
RNA polymerase II promoters can drive effective,
traceable gene knockdown in vivo
In chicken, previous studies have introduced synthetic
shRNAs via plasmids driven ubiquitously by RNA poly-
merase III (9,30,31). While the effective gene silencing
reported in these studies is encouraging, the use of
RNAi vectors described to date do not allow for directly
identiﬁable, cell type-speciﬁc expression of shRNAs. Thus,
we tested whether an RNA pol II promoter could be used
to drive the effective expression of a single transcript
encoding both a ﬂuorescent protein (to directly mark
transfected cells) and artiﬁcial miRNA (Figure 1A).
We ﬁrst tested this idea using a ubiquitously active
(RNA pol II-driven) bactin promoter, and a previously
published miRNA against Sonic Hedgehog (9) (miShh;
Figure 1A). The miShh and ﬂanking regions were placed
within the context of a miRNA30-based sequence (9) and
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cloned within the 30-UTR of red ﬂuorescent protein
(RFP). Shh is a secreted protein that is produced and
released by ﬂoor-plate cells, thus forming a gradient in
the ventral spinal cord (Figure 1B and C). When a
control bactin-RFP plasmid was injected into the central
canal of Hamburger–Hamilton (HH) stage 18 chicken em-
bryos followed by bilateral electroporation, we saw no
signiﬁcant change in the average intensity of Shh immuno-
ﬂuorescence at HH26 compared to untreated embryos
(Figure 1E; higher by 7±10.8% SEM). However, when
bactin-RFP-miShh was electroporated, we saw a
42±12.5% reduction in Shh (Figure 1G; P=0.0015).
Electroporation with either the bactin-RFP or bactin-
RFP-miShh plasmid produced strong red ﬂuorescence
making it easy to identify transfected cells in the spinal
cord (Figure 1D and F). We calculated that the transfec-
tion efﬁciency of our bilateral electroporations is
51.8%±1.3%. Therefore, an average knockdown of
42% at the protein level represents 80% of the theoret-
ical maximum that could be achieved. Since any Shh ex-
pressed prior to electroporation would be unaffected, the
results suggest that our miRNA approach very effectively
downregulates Shh in the targeted cells.
To test whether the knockdown of Shh was due to the
speciﬁc activity of the miRNA rather than global gene
downregulation, we immunolabeled sections with anti-
bodies against an array of spinal cord markers, including
HNF3b, Nkx2.2, Islet1 and Pax 7 (32,33). Although Shh is
a morphogen that speciﬁes cellular differentiation during
early neural tube development, perturbation of Shh signaling
after HH18 no longer affects spinal-cord patterning (3).
Indeed, we found that the expression patterns and
staining intensities of the markers that we used were in-
distinguishable between the different groups (Figure 2).
Our results showed that the forced, widespread expression
of miShh after HH18 did not cause gross developmental
abnormalities, and that miShh downregulates its target
gene speciﬁcally.
We further assessed the versatility of our plasmid design
by expressing different ﬂuorescent proteins [EBFP2,
hrGFPII and EGFP (data not shown)] and novel
miRNAs against a variety of endogenous target genes
(Figure 3). In each case, the plasmids expressed strong
ﬂuorescence and elicited knockdown of their targets.
The expression of a miRNA against ﬁreﬂy luciferase (9)
had no effect on the levels of the endogenous genes that we
tested (Figure 3G and H), indicating that our harnessing
of the cellular miRNA processing pathway did not in itself
elicit broad physiological toxicity. In support of this,
immunolabeling for activated caspase-3 showed no differ-
ences in cell death between control and miRNA-treated
tissues (data not shown). Thus, our plasmids elicit trace-
able, effective gene knockdown in vivo.
Cell type-speciﬁc, traceable gene knockdown in the
ﬂoor plate
We next tested whether a cell type-speciﬁc RNA Pol II
promoter/enhancer could be used to drive traceable gene
knockdown. We used the ﬂoor-plate-speciﬁc Hoxa-1
enhancer element III (34) to drive the expression of
EGFP±miShh (Figure 4A). Following bilateral electro-
poration, both Hoxa1-EGFP and Hoxa1-EGFP-miShh
Figure 1. RNA polymerase II-driven plasmids can be used to express a single transcript encoding both a ﬂuorescent protein and an effective artiﬁcial
miRNA in chicken embryos. (A) Schematic of the plasmid constructs used in this study. The stem–loop structure of the miRNA30-like cassette is
shown for an artiﬁcial miRNA against Shh (miShh). The target (sense) sequence of Shh is indicated in red. (B) Immunolabeling of cryosections of
untreated chicken spinal cords at HH26 with the 5E1 antibody shows normal distribution of Shh in the notochord (nc), ﬂoor plate (asterisks) and
adjacent ventral spinal cord. The boxed area is shown in higher power in (C), and equivalent regions are shown in (D–G). (D and F) RFP-positive
cells in the ﬂoor plate and ventral spinal cord of embryos bilaterally electroporated with the control bactin-RFP construct (D) or bactin-RFP-miShh
(E). The corresponding images showing Shh expression in each condition are shown in (F) and (G) (compare to C). Scale bar: 100 mm.
PAGE 5 OF 15 Nucleic Acids Research, 2011, Vol. 39, No. 20 e133
embryos displayed green ﬂuorescence speciﬁcally in the
ﬂoor plate (Figure 4B and insets). Relative to untreated
embryos (Figure 4C), we found no signiﬁcant change in
the average Shh immunoﬂuorescence intensity in the
Hoxa1-EGFP group (Figure 4D; higher by 10±5.6%),
whereas the average Shh intensity was reduced by
40%±19.1% following Hoxa1-EGFP-miShh treatment
(Figure 4E; P=0.0006). Immunolabeling for other spinal
cord markers showed no differences between the three
groups (data not shown). Taken together, these results
suggest that the Hoxa-1 enhancer III can drive both
bright ﬂuorescence and active miRNA to elicit traceable
gene knockdown in the chicken ﬂoor plate.
In order to assess their effectiveness in developmental
studies, we next asked whether this level of knockdown
was sufﬁcient to perturb biological function. After its
function in neural tube patterning, Shh plays two roles
during the guidance of spinal commissural axons: ﬁrst, it
collaborates with Netrin1 to attract axons toward the
ﬂoor plate (35) and second, it repels post-crossing axons
Figure 3. Constructs drive the expression of various ﬂuorescent proteins and efﬁciently knock down endogenous target genes. We tested miRNAs
against Glypican1 (miGPC1), Axonin1 (miAX1) and Wnt7a (miWnt7a). Chicken embryos were unilaterally electroporated at HH18 with
bactin-EBFP2-miGPC1 (A and B), bactin-RFP-miAX1 (C and D), bactin-hrGFPII-miWnt7a (E and F) or bactin-EBFP2-miLuc and examined
for target gene expression at HH25-26. In each case strong ﬂuorescence was detectable on the electroporated side (B, D, F and H). ISH showed
downregulation of the appropriate target gene on the electroporated side of the neural tube compared to the control side (arrows in A, C and E).
Expression of miLuc did not affect the expression of any of the endogenous genes that we tested (G; GPC1 shown as an example). Scale bar: 100mm.
Figure 2. Widespread misexpression of miRNA construct does not affect spinal cord patterning. The normal distributions of (A) HNF3b in the ﬂoor
plate, (B) Nkx2.2 in p3 precursor cells, (C) Islet-1 in motor neurons and dI3 dorsal interneurons and (D) Pax7 in precursors of dI1-6 interneurons are
shown in cross-sections of spinal cords from untreated control embryos at HH26. There was no change in the expression of these markers in embryos
that were bilaterally electroporated with bactin-RFP-miShh at HH18 (E–H, respectively). The widespread expression of the RFP-miShh transcript
was veriﬁed by strong expression of RFP throughout the neural tube (I). Scale bar: 100mm.
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along the rostrocaudal axis (3). We examined the guidance
of commissural axons using open-book preparations
(Figure 4F and G) from embryos electroporated with
Hoxa1-EGFP±miShh. In untreated control embryos,
81.3% of all DiI injection sites (n=166, from 17
embryos) displayed the normal phenotype in which com-
missural axons crossed the ﬂoor plate before turning
sharply at the contralateral ﬂoor-plate border and
extending rostrally (Figure 4H). This normal phenotype
was also seen in the majority of DiI sites from
Hoxa1-EGFP embryos (67.0%; n=115, from 20
embryos). However, the normal phenotype was observed
in only 39.7% of DiI sites from Hoxa1-EGFP-miShh
embryos (n=58, from 13 embryos; P=0.0005
compared to Hoxa1-EGFP). The speciﬁc phenotypic
abnormalities that we saw in the miShh group were
Figure 4. A ﬂoor-plate-speciﬁc miRNA construct driven by Hoxa-1 enhancer III effectively knocks down Shh in vivo. (A) Schematic of the construct.
(B) Expression of EGFP in the ﬂoor plate after bilateral electroporation of Hoxa1-EGFP. (C–E) Expression of Shh in the ﬂoor plate of an untreated
control embryo (C), and following bilateral electroporation with Hoxa1-EGFP (D) or Hoxa1-EGFP-miShh (E). Insets in D and E show EGFP
expression in the ﬂoor plate. (F) Schematic [adapted from (6)] of the open-book preparation used to analyze commissural axon trajectories (red). (G)
Top view of an open book from an embryo bilaterally electroporated with Hoxa1-EGFP-miShh showing EGFP expression in the ﬂoor plate along
the longitudinal axis. (H) Visualization of commissural axons with DiI reveals that at HH26 the axons have crossed the ﬂoor plate (dashed lines) and
extend rostrally along the contralateral ﬂoor-plate border in untreated (data not shown) and Hoxa1-EGFP embryos. (I and J) Phenotypes observed
in embryos bilaterally electroporated with Hoxa1-EGFP-miShh. Many axons made ipsilateral pathﬁnding errors and were unable to reach the
ﬂoor plate. Compare the thickness of the axon bundle distal and proximal to the ﬂoor plate (arrows in I). Those axons that did manage to cross the
ﬂoor plate often lingered at the exit site and failed to extend rostrally (asterisks). Rostral is to the top in H–J. (K) Quantiﬁcation of the effects
obtained. *P< 0.05, **P< 0.001. Scale bar: 100mm in B and C (applies also to D and E); 50 mm in G (applies also to H–J).
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consistent with the loss of Shh during commissural axon
guidance: 24.1% of injection sites showed ipsilateral
pathﬁnding errors (compared to 9.6% in Hoxa1-EGFP
embryos; P=0.0109; Figure 4I and K), and post-crossing
axons failed to make a turning decision into the longitu-
dinal axis in 31.1% of injection sites (compared to 15.7%
in Hoxa1-EGFP controls, P=0.0169; Figure 4I–K). In
contrast to these results, the bilateral electroporation of
Hoxa1-EGFP-miLuc did not cause axon pathﬁnding
abnormalities compared to controls electroporated with
Hoxa1-EGFP alone (65.9% normal phenotype; n=141
DiI sites from 24 embryos; P=0.4865), demonstrating
that the phenotypes were not due to non-speciﬁc
toxicity. Thus, the cell type speciﬁc, targeted knockdown
that is elicited by the plasmids is sufﬁciently potent to
perturb physiological gene function.
Commissural neuron-speciﬁc gene knockdown
To establish the efﬁciency of the miRNA-expressing
vectors on other gene targets and in other cell types, we
used an enhancer of the Math1 (mouse Atonal homolog)
gene to drive expression of a membrane-targeted EGFP,
followed by a miRNA against Axonin1 (AX1; also known
as TAG-1 and Contactin2). The 1.5 kb Math1 enhancer
drives speciﬁc expression in the commissural dI1 inter-
neurons of the spinal cord (24,36). The majority of
Math1-labeled axons (85%; Math1comm) cross the ﬂoor
plate (24) and project rostrally within the medial longitu-
dinal fascicle (MLF), before being deﬂected diagonally
and eventually re-converging within the intermediate lon-
gitudinal fascicle (ILF). Another later-born class of
Math1-labeled neurons (15%; Math1ipsi) occupies a
more ventral position. Their axons project ipsilaterally,
turning rostrally in the intermediate spinal cord without
contacting the ﬂoor plate (36,37) (Figure 5).
We have previously demonstrated that commissural axons
require Axonin1/TAG-1 (AX1) for correct pathﬁnding
(2,38). Axonally expressed AX1 interacts with midline-
derived NrCAM to enable axons to enter the ﬂoor plate.
When AX1 function is perturbed by dsRNA-induced
downregulation or by the addition of function-blocking
antibodies, >20% of commissural axons stall or turn at
the ipsilateral ﬂoor-plate border (2,38). Thus, we used this
well-characterized phenotype as an indicator of efﬁcient
downregulation of AX1 speciﬁcally in commissural
axons using miRNAs driven by the Math1 enhancer.
We ﬁrst identiﬁed miRNAs that successfully targeted
AX1. We designed six miRNAs (mi1AX1-mi6AX1)
against the ORF of AX1, using an online algorithm.
These were cloned into pRFPRNAi (9) and ﬁrst screened
in vitro to rapidly identify effective candidates (Figure 6).
We used a multiple transfection protocol (29) to approxi-
mate a ‘stable cell line’ of cultured cells expressing each
miRNA. Based on the expression of an RFP reporter, we
estimated that 70% of cells were transfected and we saw
similar transfection rates in all wells. Next, a myc-tagged
AX1 construct was introduced. Cells were incubated for
24 h before immunolabeling for myc and comparing the
expression levels to that observed in the control ‘empty’
pRFPRNAi condition. Of the six miRNAs that we tested,
three showed strong suppression of AX1 (mi1AX1,
mi2AX1 and mi5AX1), two showed weak knockdown
(mi3AX1 and mi4AX1) and one was ineffective in vitro
(mi6AX1). A miRNA against an unrelated gene
(miGPC1) did not affect AX1 expression.
For in vivo testing, we unilaterally electroporated
pRFPRNAi-AX1 vectors, or pRFPRNAi-miLuc as a
control. By ISH (Figure 7A and B), we found that
mi3AX1 elicited the most signiﬁcant knockdown of
AX1, while mi1AX1, mi2AX1 and mi4AX1 were moder-
ately effective (data not shown). Surprisingly, mi5AX1,
which strongly suppressed AX1 in vitro, appeared to be
ineffective in vivo. The expression of miLuc had no impact
on AX1 levels. Immunolabeling for AX1 yielded the same
results (Figure 7C and D), suggesting that mi3AX1 was an
effective miRNA to knockdown AX1 in vivo. The expres-
sion of NgCAM (another immunoglobulin superfamily
protein expressed by commissural axons) was unaffected
by either miLuc or mi3AX1, demonstrating the speciﬁcity
of knockdown (Figure 7E and F).
We next tested whether the knockdown of AX1 by
mi3AX1 was adequate to elicit axon guidance effects
Figure 5. An enhancer of the transcription factor Math-1 labels precursors of dI1 interneurons in the dorsal spinal cord. The vast majority of these
neurons (Math1comm; red) extend axons that cross the ﬂoor plate (FP), the ventral midline of the spinal cord. Only a small subset of Math1-positive
neurons, which are born later and are positioned more ventrally, extend ipsilateral projections (Math1ipsi; blue). MLF, medial longitudinal fascicle;
ILF, intermediate longitudinal fascicle.
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in vivo, and further, whether the speciﬁc population of
commissural axons labeled by theMath1 enhancer requires
AX1 for ﬂoor-plate crossing (Figure 8). We cloned
mi3AX1 or miLuc into the 30-UTR of EBFP2, in a
bactin-driven plasmid. This was co-electroporated with
a plasmid containing the Math1 enhancer driving a
membrane-bound EGFP (EGFPf), to genetically label
dI1 axons (Figure 8A). In the control conditions in
which Math1-EGFPf was co-electroporated with bactin-
EBFP2 or with bactin-EBFP2-miLuc, the majority of
embryos displayed Math1-labeled (green) axons that
grew normally across the ﬂoor plate before turning longi-
tudinally (6/7 and 12/13 embryos, respectively; data not
shown). In contrast, we found that the co-electroporation
of Math1-EGFPf with bactin-EBFP2-mi3AX1 caused
many Math1-labeled axons to stall or turn before crossing
the ﬂoor plate, creating a fascicle of green axons at the
ipsilateral ﬂoor-plate border (6/6 embryos). The position
of this aberrant longitudinal fascicle was distinct from
(and in addition to) that of the Math1ipsi axons that
normally extend within the intermediate spinal cord. The
result phenocopied the axon guidance defects that we pre-
viously reported as a result of perturbations in AX1
activity (2,38). Assessment of individual DiI injection
sites in open-book preparations showed ipsilateral errors
in 56% of DiI sites (n=99 from six embryos) in the
bact-EBFP2-mi3AX1 group (Figure 8D), compared to
4% of the DiI sites (n=51 from six embryos) in the
bact-EBFP2 group or 7.5% of DiI sites (n=53 from six
embryos) in the bact-EBFP2-miLuc group (P< 0.0001).
Taken together, the results show that mi3AX1 efﬁciently
downregulates AX1 in vivo and conﬁrm that a
subpopulation of the Math1comm axons requires AX1 for
correct guidance.
We next tested whether the Math1 enhancer itself could
drive sufﬁcient expression of ﬂuorescent protein and
mi3AX1, speciﬁcally in the dI1 neurons, to recapitulate
these guidance defects. We cloned mi3AX1 or miLuc
into the 30-UTR of Math1-EGFPf and electroporated
these constructs (Figure 8A). In the control conditions
electroporated with Math1-EGFPf alone or with
Math1-EGFPf-miLuc, the majority of embryos [66.7%
(n=nine embryos) and 69.2% (n=13), respectively] dis-
played green ﬂuorescent axons with the normal
pathﬁnding phenotype (Figure 8C and E). In contrast,
68.2% of Math1-EGFPf-mi3AX1 embryos (n=22) dis-
played green axons that turned aberrantly along the ipsi-
lateral ﬂoor-plate border, as described above, thus
Figure 6. An in vitro protocol rapidly tests the efﬁciency of multiple candidate miRNAs against Axonin1. COS-7 cells were repeatedly transfected
with pRFPRNAi vectors expressing different miRNAs (as indicated). In each case, the expression of RFP showed that the majority of cells were
transfected (A, representative image). Cells were then co-transfected with a construct driving the expression of myc-tagged Axonin1. Immunolabeling
for myc 24 h later using the 9E10 antibody (B–I) revealed the ability of the different miRNAs to suppress Axonin1 expression relative to control
conditions. The images are from one representative repeat of this experiment. Scale bar: 200 mm.
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recapitulating the expected axon guidance defects arising
from perturbation of AX1 function (Figure 8F;
P=0.0455 compared to miLuc group).
Interestingly, we observed that the severity of the axon
pathﬁnding defects in the Math1-EGFPf-mi3AX1
embryos was dependent on the age at electroporation:
87% of all moderate/severe phenotypes were observed in
embryos electroporated at <HH17.5, while 67% of all
normal phenotypes were found in embryos electroporated
at >HH18. Within each embryo, we also found that the
caudal segment of the open book was more severely
affected than the rostral end, reﬂecting the decreas-
ing ‘maturity’ of the nervous system in the rostral–caudal
axis.
Analysis of individual DiI sites in open-book prepar-
ations (Figure 8D) revealed that ipsilateral stalling or
turning errors (Figure 8G) were observed in <9% of DiI
sites following electroporation with Math-EGFPf
(n=142 from 16 embryos) or Math1-EGFPf-miLuc
(n=61 from nine embryos). In contrast, 26.9% of DiI
sites (n=182 from 20 embryos) in the Math1-EGFPf-
mi3AX1 group displayed ipsilateral errors (P=0.0011
compared to the miLuc group). Of note here is that we
inject DiI into the cell bodies of the Math1comm, but not
the Math1ipsi, subpopulation of dI1 neurons (Figure 5).
Additionally, we routinely label only commissural axons
that project within the MLF, in contact with the contra-
lateral ﬂoor-plate border, and not those that project in the
ILF. Thus, our DiI injection sites label only a sub-
population of the Math1comm axons, which may explain
the lower percentage of ipsilateral errors that we observed
in the DiI analysis of Math1-EGFPf-mi3AX1 embryos
compared to the bact-EBFP2-mi3AX1 group.
Dual activity of vectors in vivo
The plasmids contain insertion sites for two different
miRNAs. Previous reports demonstrate that both
miRNA insertion sites in the parent pRFPRNAi vectors
are active against exogenous gene targets in vitro (9,39). In
the single knockdown experiments described above, we
used either the ﬁrst miRNA insertion site (for mi3AX1)
or the second (for miShh), demonstrating that, individu-
ally, both sites can yield miRNAs that are active against
endogenous gene targets. To test whether the insertion
sites are simultaneously active in vivo, we used a single
construct encoding two miRNAs against different target
genes (Figure 9). The miRNA cassette was located in the
30-UTR of hrGFPII, in a bactin-driven construct.
We arbitrarily chose target genes whose expression
patterns partially overlapped in the developing neural
tube. The ﬁrst insertion site contained a miRNA against
the heparan sulfate proteoglycan glypican1 (GPC1), while
the second contained a miRNA against Wnt7a,
yielding bactin-hrGFPII-miGPC1-miWnt7a. To control
for saturation of the miRNA processing pathway, we
made dual expression constructs containing a miRNA
against luciferase (mi2Luc), rather than an endo-
genous gene target, in the ﬁrst or second insertion sites
(yielding bactin-hrGFPII-miGPC1-mi2Luc and bactin-
hrGFPII-mi2Luc-miWnt7a). The constructs were
electroporated, and the expression of GPC1, Wnt7a and
two closely related members of the target gene families
(GPC4 and Wnt4) was assessed 2 days later. In each
case, we found that the appropriate target gene/s was/
were knocked down without any discernible effect on
the expression of non-targeted genes. The level of silencing
for each gene was comparable to that produced by vectors
Figure 7. miRNAs against Axonin1 (AX1) effectively and speciﬁcally
knockdown Axonin-1 in vivo. Embryos were electroporated at HH17-18
with pRFPRNAi vectors driving the expression of miLuc (A, C and E)
or mi3AX1 (B, D and F) and processed at HH26 for Axonin1 in situ
hybridization (A and B), Axonin1 immunolabeling (C and D) or
NgCAM immunolabeling (E and F). The right half of the spinal
cord was targeted by electroporation, as shown by RFP expression
(insets). Axonin1 is expressed by dI1 commissural axons whose cell
bodies reside in the dorsal spinal cord (A, boxed region and detail).
Arrows show the reduction of Axonin1 levels on the electroporated side
in the presence of mi3AX1 (compare to control side). The ﬂoor-plate
(asterisks) and ventral commissure (VC) are indicated. Scale bar:
100mm.
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encoding only a single miRNA (Figure 3). Thus, both
miRNA insertion sites are simultaneously active in vivo
and their concurrent activity can drive effective, speciﬁc
downregulation of distinct target genes.
Mixing two plasmids before electroporation can add-
itionally be used to knockdown genes in different cell
types. Due to the expression of ﬂuorescent markers from
the plasmids encoding the different miRNAs, the cells
experiencing knockdown of the speciﬁc target genes can
easily be identiﬁed (Figure 10).
DISCUSSION
We have designed a simple, vector-based artiﬁcial miRNA
expression strategy that can be used to knockdown
endogenous gene expression in a cell type-speciﬁc, trace-
able manner in vivo. All constructs that we tested strongly
express a ﬂuorescent protein marker and can efﬁciently
silence target gene expression in vivo. While RNA pol
II-driven shRNAs have previously been shown to elicit
cell type-speciﬁc knockdown (11,13,15), the current
study is the ﬁrst to demonstrate in vivo that an artiﬁcial
miRNA directly coupled to a ﬂuorescent protein marker
performs effectively during development. These functional
tools offer multiple gene silencing, temporal control and
cell type speciﬁcity, to facilitate the elucidation of complex
developmental pathways.
We tested three different RNA polymerase II pro-
moters/enhancers to drive expression either ubiqui-
tously (actin promoter) or in a cell type-speciﬁc manner
Figure 8. A dI1-speciﬁc miRNA construct driven by the Math1 enhancer effectively knocks down Axonin1 in vivo. (A) Schematics of the constructs.
(B) Speciﬁc expression of EGFPf in dI1 axons after unilateral electroporation of Math1-EGFPf. (C) Top view of an open book taken from a HH26
embryo electroporated with Math1-EGFPf showing the trajectories of dI1 axons. A subset of dI1 axons turns ipsilaterally in the intermediate spinal
cord (arrow). The majority of axons grow across the ﬂoor plate (indicated by dashed lines) before turning rostrally along the contralateral ﬂoor-plate
border and extending within the MLF. The axons are later deﬂected diagonally and then re-converge to form the ILF (by HH27-28). The boxed area
indicates the equivalent regions shown in (E and F). (D) Quantiﬁcation of the phenotypes observed by DiI injection. **P< 0.001, ***P< 0.0001. (E)
Visualization of ﬂuorescent dI1 axons in embryos electroporated with Math1-EGFPf-miLuc reveals that at HH26 the majority of axons have crossed
the ﬂoor plate (dashed lines) and extend rostrally along the contralateral ﬂoor-plate border. (F) Embryos electroporated with Math1-EGFPf-mi3AX1
displayed aberrant navigation of dI1 axons. Many axons were unable to enter the ﬂoor plate, instead growing longitudinally along the ipsilateral
ﬂoor-plate border (arrows). (G) Visualization of commissural axons with DiI following electroporation with Math1-EGFPf-mi3AX1 conﬁrms that
the axons make ipsilateral turning (arrows) and stalling (asterisks) errors. Compare the phenotype to Figure 4H. Rostral is to the top in C, E–G.
Scale bar: 100mm in B, C, E (applies to F); 50 mm in G.
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(Math1 enhancer,Hoxa-1 enhancer element III). The success
of the cell type-speciﬁc approach offers a number of beneﬁts
over current techniques. First, enhancer-mediated control of
gene knockdown provides an increased precision of cell
type-speciﬁc targeting compared to manual techniques.
Since the artiﬁcial miRNA is expressed only in the cell
type of interest (and not in surrounding tissues), there is
a decreased chance of abnormal phenotypes arising sec-
ondarily as a result of local morphological and/or cell fate
changes. Second, the use of RNA pol II promoters, which
are generally weaker than those driven by RNA pol III,
decreases the chance of non-speciﬁc toxicity arising from
Figure 9. Dual silencing of endogenous target genes in the neural tube. Embryos were electroporated at HH17-18 with bactin-hrGFPII vectors
driving the dual expression of miGPC1-miLuc (A–D), miLuc-miWnt7a (E–H) or miGPC1-miWnt7a (I–L) and processed at HH26 for in situ
hybridization against GPC1, GPC4, Wnt4 and Wnt7a. The right half of the spinal cord was targeted by electroporation, as shown by the corres-
ponding images of hrGFPII ﬂuorescence (A0–L0). The appropriate target genes were downregulated (arrows; compare to non-electroporated side),
without discernible off-target effects. Scale bar: 100 mm.
Figure 10. Combinatorial use of vectors in vivo. Embryos were bilaterally co-electroporated at HH18 with a mixture of vectors, as indicated, and
assessed at HH26. The combined electroporation of plasmids drove the distinct expression of ﬂuorescent proteins and several different miRNAs in
independent cell types: dI1 commissural neurons express a Math1-driven construct (green) and the ﬂoor-plate cells express a Hoxa1-driven construct
(blue).
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saturation of the miRNA-processing pathway (11).
Finally, the combined used of constructs driven by differ-
ent promoters enables the simultaneous knockdown of
different genes in independent regions of the neural tube
from a single electroporation event, thus enhancing the
combinatorial possibilities of in vivo RNAi (Figure 10).
In the neural tube, several other enhancers/promoters
have been shown to drive cell type-speciﬁc expression,
for example, in motor neurons [HB9; (40)], primary sen-
sory neurons [CREST3; (41)], subpopulations of dorsal
interneurons (37) and other cell types (42). Thus, the plas-
mid design may facilitate many developmental studies of
diverse subsets of neurons and their targets.
Several different ﬂuorescent reporters were all strongly
expressed and can be easily exchanged in each construct.
This feature facilitates the concurrent use of two or more
different constructs in vivo since their simultaneous
activity in independent cell types can be identiﬁed with
different ﬂuorescent markers. This is of critical relevance
to developmental studies examining highly intricate
cellular and molecular pathways. The ability to simultan-
eously knockdown multiple different genes in independent
cells types, combined with the ability to directly identify
the cells experiencing knockdown of particular gene/s,
offers a signiﬁcant advantage over current techniques.
The direct coupling of the ﬂuorescent marker with the
artiﬁcial miRNA within a single transcript also allows
more accurate assessment of targeted cells, compared to
commonly used designs where the miRNA and marker are
encoded by different transcripts that are derived from in-
dependent plasmids or promoters. The ability to easily
exchange the ﬂuorescent protein that is expressed also
enhances the ﬂexibility of the plasmid application in con-
junction with other ﬂuorescent labeling methods (e.g. DiI
labeling and ﬂuorescent immunohistochemistry). Previous
studies have shown that a miRNA precursor located in the
30-UTR only moderately inhibits expression of a linked,
protein-coding ORF (due to processing of the primary
transcript by Drosha) (16,17). Consistent with these
ﬁndings, we had no problems detecting ﬂuorescence in
any of our experiments.
A crucial factor in the use of miRNA-based plasmids as
functional tools in developmental biology is the selection
of effective, speciﬁc miRNAs (43). This process should
incorporate the identiﬁcation of several independent
miRNAs to conﬁrm an observed phenotype, negative
controls (scrambled and/or unrelated miRNAs) and
rescue constructs. To facilitate this process, we have
described a quick in vitro protocol as a primary screening
method of novel miRNAs. The multiple transfection of a
given miRNA-expressing plasmid maximizes the number
of cells expressing the miRNA, approximating a ‘stable
cell line’ into which other plasmids (providing a readout
of knockdown efﬁciency, off-target effects or
cross-reactivity) can be co-transfected. We found that
one of our miRNAs against AX1 was effective in vitro
but not in vivo. While this ﬁnding was unexpected, it is
consistent with another previous report (44) and under-
scores that in vitro efﬁcacy does not necessarily apply
in vivo. Still, our in vitro protocol provides a platform
for further in vivo testing of novel miRNAs.
In our AX1 knockdown experiments, we observed
decreasing phenotypic effects with increasing age at elec-
troporation. Importantly, these effects are entirely consist-
ent with the onset of AX1 expression [HH19 in the lumbar
spinal cord (38)] and its long half-life [>100 h in DRG
neurons (45)]. The ﬁndings support the idea that any
AX1 protein that is expressed prior to the introduction
of the miRNA is sufﬁcient and persistent enough to
allow correct axon pathﬁnding. They also illustrate an
important consideration for the timing of application of
the plasmids in vivo: following transfection, the transcrip-
tion and processing of ‘active’ miRNAs capable of
eliciting gene knockdown may take several hours.
Our results show that two endogenous genes can be
targeted from a single vector. This provides a number of
advantages for functional analyses in vivo; for example, by
addressing redundancy in gene families, or enabling com-
binatorial gene knockdowns to identify genetic inter-
actions. The simultaneous use of multiple cell type-
speciﬁc vectors would enable many different genes to be
knocked down in independent regions of the spinal cord,
to investigate complex cellular and molecular interactions
in a manner that is rapid, precise and inexpensive.
Finally, the possibility to ﬂuorescently label a few gen-
etically modiﬁed cells in a ‘wild-type’ environment will
also provide a basis for time-lapse imaging of navigating
axons or migrating cells in organotypic cultures. The com-
bination of the novel tools with ex ovo RNAi (5) will allow
for analysis of cell migration, axon guidance and synapse
formation in the brain (in particular in the cerebellum) in a
temporally controlled and cell type-speciﬁc manner. In
contrast to such approaches in mice, where cell type-
speciﬁc promoters driving Cre expression must be used,
spatial and temporal control of gene silencing is facilitated
in the chicken using these novel tools. Additionally, since
our results suggest that, in principle, any RNA pol II
promoter could be used, the applicability of the construct
design may extend beyond that of the chicken neural tube.
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